A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma

Chengting Wu; Xinyuan Chen; Yu Zhang; Yuanqin Du; Jian Xu; Yujiao Peng; Lu Lu; Jingjing Huang; Hongna Huang

doi:10.1371/journal.pone.0322158

Loading metrics

Open Access

Peer-reviewed

Research Article

A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma

Chengting Wu ,

Contributed equally to this work with: Chengting Wu, Xinyuan Chen

Roles Investigation, Methodology, Writing – original draft

Affiliation Guangxi University of Chinese Medicine, Nanning, China
⨯
Xinyuan Chen ,

Contributed equally to this work with: Chengting Wu, Xinyuan Chen

Roles Investigation, Methodology, Writing – original draft

Affiliation Guangxi University of Chinese Medicine, Nanning, China
⨯
Yu Zhang,

Roles Data curation

Affiliation Guangxi University of Chinese Medicine, Nanning, China
⨯
Yuanqin Du,

Roles Data curation

Affiliation Guangxi University of Chinese Medicine, Nanning, China
⨯
Jian Xu,

Roles Software

Affiliation Guangxi University of Chinese Medicine, Nanning, China
⨯
Yujiao Peng,

Roles Validation

Affiliation Guangxi University of Chinese Medicine, Nanning, China
⨯
Lu Lu,

Roles Validation, Visualization

Affiliation Guangxi University of Chinese Medicine, Nanning, China
⨯
Jingjing Huang ,

Roles Writing – review & editing

* E-mail: 55869563@qq.com (JH); 18776985262@163.com (HH)

Affiliations The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China, Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Nanning, China

https://orcid.org/0000-0002-4936-0838

⨯
Hongna Huang

Roles Writing – review & editing

* E-mail: 55869563@qq.com (JH); 18776985262@163.com (HH)

Affiliation The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China
⨯

A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma

Chengting Wu,
Xinyuan Chen,
Yu Zhang,
Yuanqin Du,
Jian Xu,
Yujiao Peng,
Lu Lu,
Jingjing Huang,
Hongna Huang

Published: June 4, 2025
https://doi.org/10.1371/journal.pone.0322158

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.